Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Mir-21 in Cardiovascular Disease: New Insights and Emerging Therapeutic Potential Publisher



Mollajan E1 ; Yazdani S2 ; Ghasemzadeh M3 ; Mozhgani SH4, 5
Authors

Source: Discover Applied Sciences Published:2025


Abstract

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Among various molecular regulators, microRNAs (miRNAs), small noncoding RNAs averaging 18–24 nucleotides have emerged as key players in CVD pathophysiology. miR-21, particularly, has been widely studied due to its involvement in inflammation, fibrosis, and cardiomyocyte survival. While some studies highlight its cardioprotective functions, others suggest it may contribute to adverse remodeling and disease progression. This review critically examines the dual role of miR-21 in CVDs, exploring both supportive and conflicting evidence. Additionally, miR-21’s potential as a diagnostic biomarker and therapeutic target is discussed while outlining key challenges and future research directions for clinical translation. © The Author(s) 2025.
Other Related Docs
7. Micrornas and Exosomes: Cardiac Stem Cells in Heart Diseases, Pathology Research and Practice (2022)
11. Carvedilol Alters Circulating Mir-1 and Mir-214 in Heart Failure, Pharmacogenomics and Personalized Medicine (2020)
18. Mirna Expression in Covid-19, Gene Reports (2022)